Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
ASTRAZENECA LP et al v.BREATH LIMITED et al
Case Number:
1:08-cv-01512
Court:
Nature of Suit:
Judge:
Firms
- Duane Morris
- Hill Wallack
- Hyland Levin
- Klehr Harrison
- McCarter & English
- Saiber LLC
- Saul Ewing
- Stevens & Lee
- Walsh Pizzi
- Wilentz Goldman
Companies
Sectors & Industries:
-
December 05, 2016
Apotex Can't Ditch Subpoena From Sandoz, Court Says
A New Jersey federal judge on Monday rejected Apotex Inc.'s request to quash a subpoena Sandoz Inc. served on Apotex's business partner during the damages phase of a patent infringement lawsuit both drugmakers and others won last year against AstraZeneca over pediatric asthma medication.
-
November 17, 2016
Apotex Pushes To Have Late Sandoz Subpoena Tossed
Apotex Inc. on Wednesday asked a New Jersey federal judge to kill a subpoena Sandoz Inc. sent to one of Apotex's business partners during the damages stage of a patent infringement suit both drugmakers won against AstraZeneca, arguing the subpoena was filed a year too late and is irrelevant to the case.
-
February 13, 2015
AstraZeneca's Kid Asthma Drug Patent Deemed Obvious
A New Jersey federal judge on Friday opened the door for Sandoz Inc., Apotex Inc. and other competitors of AstraZeneca PLC to launch generic versions of its pediatric asthma medication, finding that a patent for sterilizing the drug was invalid as obvious.
-
June 04, 2014
AstraZeneca Asthma Med Injunction Rolled Into Merits Trial
A New Jersey federal judge on Wednesday didn't rule on whether she would stop AstraZeneca PLC's competitors from launching generic versions of its pediatric asthma medication, saying "game-changing" developments in the claim construction of a patent for sterilizing the drug prompted deeper consideration.
-
April 02, 2013
AstraZeneca's Kid Asthma Drug Patent Invalid, Judge Says
A New Jersey federal judge on Monday shot down AstraZeneca PLC's bid to block four generic drugmakers from producing no-name versions of the pharmaceutical giant's pediatric asthma medication, and declared one of the company's patents invalid.
-
August 14, 2012
AstraZeneca Looks To Block Generic Pulmicort
AstraZeneca PLC on Monday asked a New Jersey federal court to block the manufacture and distribution of a generic version of its Pulmicort Respules asthma medication for children by Breath Ltd.